Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Unknown 4Completed 2

Sponsor Class

OTHER 39NIH 7INDUSTRY 6OTHER_GOV 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 2Rectal Neoplasms 1Colorectal Neoplasms 1

Interventions

apatinib 25Cisplatin 19Capecitabine 17Irinotecan 16Cyclophosphamide 16fludarabine 14Radiotherapy 12Oxaliplatin 12Drug Therapy 12camrelizumab 11Paclitaxel 11S 1 (combination) 10Docetaxel 10Carboplatin 10Fluorouracil 9Blood Specimen Collection 9Bevacizumab 9Nivolumab 8tislelizumab 7Radiation 7Pemetrexed 7Gemcitabine 7Erlotinib Hydrochloride 7Surgical Procedures, Operative 6Neoadjuvant Therapy 6Albumin-Bound Paclitaxel 6toripalimab 5anlotinib 5XELOX 5Tamoxifen 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER_GOV × Folfox protocol × Clear all
NCT03940131 2022-04-06

REPAN

King Abdullah Medical City

Phase 2 Unknown
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

King Abdullah Medical City

Phase 2/3 Unknown
338 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03939962 2022-01-26

Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma

Henan Cancer Hospital

Phase 2 Unknown
60 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04155671 2019-11-07

POF Versus FOLFOX Plus IP Paclitaxel in AGC

Fujian Cancer Hospital

Phase 2 Unknown
260 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡